DAI-10 is as good as DAI-30 in schizophrenia

Eur Neuropsychopharmacol. 2012 Oct;22(10):747-50. doi: 10.1016/j.euroneuro.2012.02.008. Epub 2012 Mar 21.

Abstract

Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAI-10) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / therapeutic use
  • Attitude to Health*
  • Clozapine / administration & dosage
  • Clozapine / therapeutic use
  • Cognitive Science / methods
  • Drug Therapy, Combination
  • Female
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / therapeutic use
  • Indoles / administration & dosage
  • Indoles / therapeutic use
  • Male
  • Medication Adherence*
  • Middle Aged
  • Pharmacology, Clinical / methods
  • Psychiatric Status Rating Scales*
  • Psychometrics / methods
  • Reproducibility of Results
  • Schizophrenia / drug therapy*
  • Schizophrenia / physiopathology
  • Schizophrenic Psychology
  • Self Report
  • Work Simplification

Substances

  • Antipsychotic Agents
  • Imidazoles
  • Indoles
  • sertindole
  • Clozapine